Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
Xiangpeng Wang,
No information about this author
Xiaoxia Xue,
No information about this author
Mingshi Pang
No information about this author
et al.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(8)
Published: Aug. 1, 2024
Abstract
Currently,
cancer
is
still
a
leading
cause
of
human
death
globally.
Tumor
deterioration
comprises
multiple
events
including
metastasis,
therapeutic
resistance
and
immune
evasion,
all
which
are
tightly
related
to
the
phenotypic
plasticity
especially
epithelial–mesenchymal
(EMP).
cells
with
EMP
manifest
in
three
states
as
transition
(EMT),
partial
EMT,
mesenchymal–epithelial
transition,
orchestrate
switch
heterogeneity
tumor
via
transcriptional
regulation
series
signaling
pathways,
transforming
growth
factor‐β,
Wnt/β‐catenin,
Notch.
However,
due
complicated
nature
EMP,
diverse
process
not
fully
understood.
In
this
review,
we
systematically
conclude
biological
background,
regulating
mechanisms
well
role
therapy
response.
We
also
summarize
range
small
molecule
inhibitors,
immune‐related
approaches,
combination
therapies
that
have
been
developed
target
for
outstanding
EMP‐driven
deterioration.
Additionally,
explore
potential
technique
EMP‐based
mechanistic
investigation
research,
may
burst
vigorous
prospects.
Overall,
elucidate
multifaceted
aspects
progression
suggest
promising
direction
treatment
based
on
targeting
EMP.
Language: Английский
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8972 - 8972
Published: Aug. 17, 2024
Epithelial-mesenchymal
transition
(EMT)
is
a
process
in
which
an
epithelial
cell
undergoes
multiple
modifications,
acquiring
both
morphological
and
functional
characteristics
of
mesenchymal
cell.
This
dynamic
initiated
by
various
inducing
signals
that
activate
numerous
signaling
pathways,
leading
to
the
stimulation
transcription
factors.
EMT
plays
significant
role
cancer
progression,
such
as
metastasis
tumor
heterogeneity,
well
drug
resistance.
In
this
article,
we
studied
molecular
mechanisms,
epigenetic
regulation,
cellular
plasticity
EMT,
microenvironmental
factors
influencing
process.
We
included
vivo
vitro
models
investigation
clinical
implications
use
curing
oncological
patients
targeting
its
therapies.
Additionally,
review
concludes
with
future
directions
challenges
wide
field
EMT.
Language: Английский
Negligible Long-Term Impact of Nonlinear Growth Dynamics on Heterogeneity in Models of Cancer Cell Populations
Bulletin of Mathematical Biology,
Journal Year:
2025,
Volume and Issue:
87(2)
Published: Jan. 3, 2025
Abstract
Linear
compartmental
models
are
often
employed
to
capture
the
change
in
cell
type
composition
of
cancer
populations.
Yet,
these
populations
usually
grow
a
nonlinear
fashion.
This
begs
question
how
linear
can
successfully
describe
dynamics
types.
Here,
we
propose
general
modeling
framework
with
part
capturing
growth
and
transitions.
We
prove
that
this
model
asymptotically
equivalent
those
governed
only
by
its
under
wide
range
assumptions
for
growth.
Language: Английский
Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma
Kewei Song,
No information about this author
Chenhui Ma,
No information about this author
Baohong Gu
No information about this author
et al.
Thoracic Cancer,
Journal Year:
2023,
Volume and Issue:
14(31), P. 3069 - 3079
Published: Sept. 17, 2023
Abstract
Esophageal
cancer
(EC)
occupies
the
seventh
spot
of
most
prevalent
malignancy
ailments
worldwide
and
sixth
leading
cause
cancer‐related
death.
squamous
cell
carcinoma
(ESCC)
is
also
predominant
histological
subtype
EC,
cisplatin
(DDP)
commonly
used
as
a
first‐line
chemotherapeutic
drug
for
late
advanced
stages
disease.
However,
emergence
resistance
during
clinical
treatment
possesses
significant
challenge
to
therapeutic
success
patient
outcomes.
Collectively,
epithelial‐mesenchymal
transformation
(EMT)
process
in
which
transcription
factors
are
induced
regulate
expression
epithelial
stromal
markers
promote
differentiation
cells
into
cells.
Recent
studies
have
demonstrated
close
association
between
EMT
chemotherapy
tumor
cells,
with
concrete
evidence
reciprocal
reinforcement.
Therefore,
this
review,
we
elucidate
molecular
mechanism
underlying
ESCC,
shed
light
on
mechanisms
driving
DDP
resistance,
provide
insights
intricate
interplay
ESCC.
We
aimed
some
new
hypotheses
perspectives
that
may
address‐inform
future
strategies
ESCC
treatment.
Language: Английский
Protocol for inferring epithelial-to-mesenchymal transition trajectories from single-cell RNA sequencing data using R
STAR Protocols,
Journal Year:
2024,
Volume and Issue:
5(1), P. 102819 - 102819
Published: Jan. 5, 2024
The
epithelial-to-mesenchymal
transition
(EMT)
provides
crucial
insights
into
the
metastatic
process
and
possesses
prognostic
value
within
cancer
context.
Here,
we
present
COMET,
an
R
package
for
inferring
EMT
trajectories
inter-state
rates
from
single-cell
RNA
sequencing
data.
We
describe
steps
finding
optimal
number
of
genes
a
specific
context,
estimating
EMT-related
trajectories,
fitting
continuous-time
Markov
chain
to
inferred
rates.
Language: Английский
Cell-state transitions and frequency-dependent interactions among subpopulations together explain the dynamics of spontaneous epithelial-mesenchymal heterogeneity in breast cancer
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 8, 2023
Abstract
Individual
cells
in
a
tumour
can
be
distributed
among
Epithelial
(E)
and
Mesenchymal
(M)
cell-states,
as
characterised
by
the
levels
of
canonical
E
M
markers.
Even
after
(E-M)
subpopulations
are
isolated
then
cultured
independently,
E-M
heterogeneity
re-equilibrate
each
population
over
time,
sometimes
regaining
initial
distribution
parental
cell
population.
However,
it
remains
unclear
which
population-level
processes
give
rise
to
dynamical
changes
observed
experimentally,
including
1)
differential
growth,
2)
cell-state
switching,
3)
frequency-dependent
growth
or
state-transition
rates.
Here,
we
analyse
necessity
these
three
explaining
dynamics
distributions
PMC42-LA
HCC38
breast
cancer
cells.
We
find
that
differences
subpopulations,
with
without
any
interactions
(cooperation
suppression)
sub-populations,
insufficient
explain
dynamics.
This
insufficiency
is
ameliorated
transitions,
albeit
at
slow
rates,
both
data.
Further,
our
models
predict
treatment
TGFβ
signalling
JAK2/3
inhibitors
could
significantly
enhance
transition
rates
from
state
state,
but
does
not
prevent
transitions
M.
Finally,
devise
selection
criterion
identify
next
most
informative
time
points
for
future
experimental
data
optimally
improve
identifiability
estimated
best
fit
model
parameters.
Overall,
study
identifies
necessary
shaping
Language: Английский